Impressive Monotherapy Activity of MDNA11 Observed in 2L/3L Patients and in Patients with ICI Exposure as Last Treatment Line

Impressive Monotherapy Activity of MDNA11 Observed in 2L/3L Patients and in Patients with ICI Exposure as Last Treatment Line

Impressive Monotherapy Activity of MDNA11 Observed in 2L/3L Patients and in Patients with ICI Exposure as Last Treatment Line

Format

JPEG

Source

Medicenna Therapeutics Corp.

Downloads